Early results on modification of combined modality treatment (chemotherapy and surgery) for testicular cancer.

Early results of modified combined modality of treatment (chemotherapy and surgery) of 58 patients with nonseminoma of the testis treated in the Institute of Oncology in Warsaw from January 1983 to December 1985 indicated a significant improvement in comparison to the preceding period of time (70 vs. 80% probability of 5-year survival). The treatment was well tolerated and no patient refused therapy. The authors suggest that this improvement can depend on using a more effective program of chemotherapy in half the patients (VAB-6) and the majority of less advanced treated cases than in the last period. This problem will be the subject of further investigation.